Black Rock Inc. Biogen Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Black Rock Inc. holds 14,538,497 shares of BIIB stock, worth $2.3 Billion. This represents 0.08% of its overall portfolio holdings.
Number of Shares
14,538,497
Previous 14,144,988
2.78%
Holding current value
$2.3 Billion
Previous $3.05 Billion
10.5%
% of portfolio
0.08%
Previous 0.07%
Shares
13 transactions
Others Institutions Holding BIIB
# of Institutions
1,036Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.63 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.58 Billion2.37% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.16 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$810 Million0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY5.1MShares$806 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...